Ausgabe 3/1999
Inhalt (11 Artikel)
Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy
Micaela Hernberg
Micrometastatic bone marrow involvement: detection and prognostic significance
S Braun, K Pantel
Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)
A Nagler, R Condiotti, R Rabinowitz, M Schlesinger, M Nguyen, LWMM Terstappen
Topoisomerase II-mediated alterations of K562 drug resistant sublines
R Zhou, Y Wang, A Gruber, R Larsson, E Castaños-Vèlez, E Liliemark
The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer
S Basu, M Khanra, B Dash, J Majumdar, J Biswas, P Chaudhuri
The effect of two different doses of oral clodronate on pain in patients with bone metastases
A Arican, F İçli, H Akbulut, M Çakir, O Şencan, M Samur, N Açikgöz, A Demirkazik
Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone
BP O’Neill, TM Habermann, TE Witzig, M Rodriguez
A case of resectable lung adenocarcinoma associated with sarcoidosis
H Yanagawa, H Goto, K Maniwa, F Ogushi, K Takahashi, Y Monden, T Hirose, N Sano, S Sone